CHATHAM, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announced that Seth Lederman, M.D., Tonix’s Chief Executive Officer, will be participating in a fireside chat at the 2025 Cantor Global Healthcare Conference 2025 on Thursday, September 4, 2025 at 1:35 PM ET. A webcast of the fireside chat will be available on the Events ...